Navigation Links
Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia
Date:3/26/2012

SAN DIEGO, March 26, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced efficacy and safety results from a Phase II trial of NBI-98854 in 37 tardive dyskinesia patients. For the final analysis, data from one site was removed due to the inconsistent and incorrect application of the efficacy assessment protocol. With this site removed, the results showed a significant reduction in tardive dyskinesia symptoms at end of two weeks of active treatment with 50mg once-daily doses of NBI-98854.

"This Phase II trial was extremely informative. NBI-98854 displayed the efficacy and safety data we expected to see in both the 12.5mg and 50mg doses," said Chris O'Brien, Chief Medical Officer of Neurocrine Biosciences. "While we had data inconsistencies at one site, this study has provided us with the necessary information and confidence to move forward into the larger Phase IIb trials as planned."

After database lock and unblinding of study data, the pre-specified statistical assessment was conducted and the normal quality control evaluation of the output performed. An inconsistent pattern of Abnormal Involuntary Movement Scale (AIMS) scores emerged at one of the eight sites that was not evident during the blinded data review. Potential errors in randomization and drug exposure as causes for this data inconsistency were ruled out. However, a review of videotaped AIMS assessments at this single site noted discrepancies between the clinical score and the video record which were well outside of the variability associated with the AIMS. Additionally, videotaped AIMS assessments were reviewed at other sites and found to be administered appropriately.

Based on these findings, the AIMS data from this single site was removed and the statistical assessment was repeated. This post-hoc analysis demonstrated a clinically meaningful and statistically signific
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
2. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock
3. Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.
4. Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference
6. Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
8. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
9. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... MOUNTAIN VIEW, Calif. , Aug. 4, 2015 /PRNewswire/ ... James H. Mackaness , who had served as ... officer since 2012, has resigned his positions with the ... financial officer position at another company. Mr. Mackaness intends ... the Company,s second quarter earnings announcement and 10-Q filing. ...
(Date:8/4/2015)... , Aug. 4, 2015 Governor Tom Wolf ... company that develops and markets implants in the spine and ... Hanover Township , Northampton County ... move that will create 25 new, full-time jobs. ... and create more than two dozen, high-paying jobs ...
(Date:8/4/2015)... , Aug. 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: ... , M.B., Ch.B., Sangamo,s executive vice president, research and ... Sangamo,s ZFP Therapeutic ® development programs and an ... on Tuesday, August 11, 2015, at the 2015 Wedbush ... New York, NY . ...
Breaking Medicine Technology:IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 3Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2
... demand for medical devices,has been increasing in recent ... is so high because local manufacturers concentrate mainly ... in most,Russian hospitals and clinics are obsolete and ... attractive also for foreign manufacturers. , ...
... FORD, Pa., Jan. 29 Endo Pharmaceuticals (Nasdaq: ... it has concluded its research collaboration with Alexza Pharmaceuticals, ... inhaled fentanyl product for the treatment of breakthrough pain ... fentanyl (AZ-003/EN-3284), has completed Phase I clinical testing and ...
Cached Medicine Technology:Foreign Medical Devices are in High Demand in Russia 2Foreign Medical Devices are in High Demand in Russia 3Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 2Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 3
(Date:8/4/2015)... ... ... Sponsored by Gila River Casinos, the charity event helps raise funds and ... to the New Foundation AZ spokesperson , the organization is still looking for ... foursome for the tournament, as well as getting their company advertised on a banner ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... products, announces the Assisted Dumbbell Bench Rack, a fitness invention that eliminates the ... , "The Gym, Health and Fitness Clubs industry is worth $30 billion," says ...
(Date:8/4/2015)... ... August 04, 2015 , ... Exsurco Medical, ... of Tissue Banks (AATB) as an Affiliate Member. Exsurco Medical finds this ... to save and improve lives by promoting the safety, quality and availability of ...
(Date:8/4/2015)... ... ... assistPoint Partners, LLC is proud to announce a ... Through a secure web portal, assistPoint connects Life Sciences, Patients and Providers together ... and workflow solution. This provides cancer center patient advocates, financial counselors and business ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Atlantic Health ... Great Place to Work® and Fortune among the top five in their list of ... organization of Morristown, Overlook, Newton and Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:assistPoint.com Web Site Launched 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4
... to detect dementia so that it can be used ... test called National Institute //of Ageing's Consortium to Establish ... only ten minutes to administer. ,Researchers had focused ... stages often go undetected. They used a standardized diagnostic ...
... known that HIV patients are at an increased risk of ... shows // aggressive antiretroviral therapy may help lower that risk. ... therapy was associated with a lower incidence of Kaposi sarcoma ... more than 7,300 patients infected with HIV and the data ...
... reduction in inflammation can be achieved by a diet high ... such as salmon or mackerel. This is supported by the ... from an essential fatty acid in fish oil. ... fatty acids. Eating fatty fish is beneficial to patients with ...
... in the building behind me, starving to death, " Mark ... we smile together, and we talk together. She is my ... ,Members of the US Congress said on Saturday that ... at saving the life of Terri Schiavo, the brain damaged ...
... the drug rasagiline to standard treatment with levodopa can ... spend suffering from motor fluctuations they experience during the ... oral rasagiline to the drug entacapone, which must be ... around 690 patients. Both of the additional drugs were ...
... which examined the tobacco byproducts in the urine samples ... // themselves by thinking that they are getting fewer ... ,No significant difference was found in the amount ... the type of cigarettes they smoked nor there was ...
Cached Medicine News:
... Tupper's Universal Hand Holder and ... fixate the hand in any position ... with skin or tendon hooks, fixate ... Holder. With the patient's hand held ...
Stryker Instruments, the leader in cordless power, advances orthopaedics with the power, speed, versatility, reliability and performance through its heavy duty powered instruments....
... iso-centered c-arm with its integrated ... to position in the sterile ... x-ray tube head, three position ... control provide convenient access to ...
... The SmartPLUG from Medennium is ... the "punctum" or tear duct, and ... is designed to fit a range ... flexible thermosensitive acrylic material, SmartPLUG adjusts ...
Medicine Products: